Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 28, 2016
Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat
Jeffrey S Dover, Jeffrey M Kenkel, Alastair Carruthers, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 28, 2016
Overview of ATX-101 (Deoxycholic Acid Injection): A Nonsurgical Approach for Reduction of Submental Fat
Steven H Dayan, Shannon Humphrey, Derek H Jones, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
May 21, 2015
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines
Jean Carruthers, Alexander Rivkin, Lisa Donofrio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 21, 2010
Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis
Stuart A Yablon, Mitchell F Brin, Amanda M VanDenburgh, et al.
Journal of the American Academy of Dermatology
|
July 20, 2016
ATX-101 for reduction of submental fat: A phase III randomized controlled trial
Shannon Humphrey, Jonathan Sykes, Jonathan Kantor, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
May 24, 2014
An interrater and intrarater reliability study of 3 photographic scales for the classification of perioral aesthetic features
Joel L Cohen, Jane Thomas, Deepali Paradkar, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 18, 2015
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction
Derek H Jones, Jean Carruthers, John H Joseph, et al.
Aesthetic Surgery Journal
|
February 6, 2018
Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials
Steven H Dayan, Joel Schlessinger, Kenneth Beer, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 9, 2014
Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial
Marion Moers-Carpi, Jean Carruthers, Steven Fagien, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 28, 2016
Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat
Jeffrey S Dover, Jeffrey M Kenkel, Alastair Carruthers, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 28, 2016
Overview of ATX-101 (Deoxycholic Acid Injection): A Nonsurgical Approach for Reduction of Submental Fat
Steven H Dayan, Shannon Humphrey, Derek H Jones, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
May 21, 2015
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines
Jean Carruthers, Alexander Rivkin, Lisa Donofrio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 21, 2010
Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis
Stuart A Yablon, Mitchell F Brin, Amanda M VanDenburgh, et al.
Journal of the American Academy of Dermatology
|
July 20, 2016
ATX-101 for reduction of submental fat: A phase III randomized controlled trial
Shannon Humphrey, Jonathan Sykes, Jonathan Kantor, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
May 24, 2014
An interrater and intrarater reliability study of 3 photographic scales for the classification of perioral aesthetic features
Joel L Cohen, Jane Thomas, Deepali Paradkar, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 18, 2015
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction
Derek H Jones, Jean Carruthers, John H Joseph, et al.
Aesthetic Surgery Journal
|
February 6, 2018
Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials
Steven H Dayan, Joel Schlessinger, Kenneth Beer, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 9, 2014
Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial
Marion Moers-Carpi, Jean Carruthers, Steven Fagien, et al.
Page
of 2